BDBM102342 US10562854, No. C19::US8536181, C19::US9278930, C19

SMILES Oc1c(CNC2CCCCNC2=O)ccn(Cc2ccccc2)c1=O

InChI Key InChIKey=UTHFJVFVBLVONK-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 102342   

TargetEgl nine homolog 1(Human)
Aerpio Therapeutics

US Patent
LigandPNGBDBM102342(US10562854, No. C19 | US8536181, C19 | US9278930, ...)
Affinity DataIC50:  1.20E+4nMAssay Description:EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetVascular endothelial growth factor A(Human)
Aerpio Therapeutics

US Patent
LigandPNGBDBM102342(US10562854, No. C19 | US8536181, C19 | US9278930, ...)
Affinity DataIC50:  6.29E+4nMAssay Description:ELISA assay using VEGF.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent